Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Assessing genome-wide copy number aberrations and copy-neutral loss-of-heterozygosity as best practice: An evidence-based review from the Cancer Genomics Consortium working group for plasma cell disorders.

Pugh TJ, Fink JM, Lu X, Mathew S, Murata-Collins J, Willem P, Fang M; Cancer Genomics Consortium Plasma Cell Disorders Working Group.

Cancer Genet. 2018 Dec;228-229:184-196. doi: 10.1016/j.cancergen.2018.07.002. Epub 2018 Oct 5. Review.

PMID:
30393007
2.

Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma.

Herrera AF, Rodig SJ, Song JY, Kim Y, Griffin GK, Yang D, Nikolaenko L, Mei M, Bedell V, Dal Cin P, Pak C, Alyea EP, Budde LE, Chen R, Chen YB, Chan WC, Cutler CS, Ho VT, Koreth J, Krishnan A, Murata-Collins JL, Nikiforow S, Palmer J, Pihan GA, Pillai R, Popplewell L, Rosen ST, Siddiqi T, Sohani AR, Zain J, Kwak LW, Weisenburger DD, Weinstock DM, Soiffer RJ, Antin JH, Forman SJ, Nademanee AP, Armand P.

Biol Blood Marrow Transplant. 2018 Mar;24(3):514-520. doi: 10.1016/j.bbmt.2017.11.023. Epub 2017 Nov 28.

PMID:
29196080
3.

Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of TP53 mutational status.

Aldoss I, Pham A, Li SM, Gendzekhadze K, Afkhami M, Telatar M, Hong H, Padeganeh A, Bedell V, Cao T, Khaled SK, Malki MMA, Salhotra A, Ali H, Aribi A, Palmer J, Aoun P, Spielberger R, Stein AS, Snyder D, O'Donnell MR, Murata-Collins J, Senitzer D, Weisenburger D, Forman SJ, Pullarkat V, Marcucci G, Pillai R, Nakamura R.

Haematologica. 2017 Dec;102(12):2030-2038. doi: 10.3324/haematol.2017.172544. Epub 2017 Sep 29.

4.

Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation.

Herrera AF, Mei M, Low L, Kim HT, Griffin GK, Song JY, Merryman RW, Bedell V, Pak C, Sun H, Paris T, Stiller T, Brown JR, Budde LE, Chan WC, Chen R, Davids MS, Freedman AS, Fisher DC, Jacobsen ED, Jacobson CA, LaCasce AS, Murata-Collins J, Nademanee AP, Palmer JM, Pihan GA, Pillai R, Popplewell L, Siddiqi T, Sohani AR, Zain J, Rosen ST, Kwak LW, Weinstock DM, Forman SJ, Weisenburger DD, Kim Y, Rodig SJ, Krishnan A, Armand P.

J Clin Oncol. 2017 Jan;35(1):24-31. Epub 2016 Oct 24.

5.

Philadelphia chromosome as a recurrent event among therapy-related acute leukemia.

Aldoss I, Stiller T, Song J, Al Malki M, Ali H, Salhotra A, Aribi A, Khaled S, Gaytan P, Murata-Collins J, Palmer J, Snyder D, O'Donnell M, Nakamura R, Stein AS, Forman SJ, Marcucci G, Pullarkat V.

Am J Hematol. 2017 Feb;92(2):E18-E19. doi: 10.1002/ajh.24604. No abstract available.

6.

Cyclin D1 expression in peripheral T-cell lymphomas.

Song JY, Song L, Herrera AF, Venkataraman G, Murata-Collins JL, Bedell VH, Chen YY, Kim YS, Tadros R, Nathwani BN, Weisenburger DD, Feldman AL.

Mod Pathol. 2016 Nov;29(11):1306-1312. doi: 10.1038/modpathol.2016.136. Epub 2016 Jul 29.

7.

Cyclin D1 depletion induces DNA damage in mantle cell lymphoma lines.

Mohanty S, Mohanty A, Sandoval N, Tran T, Bedell V, Wu J, Scuto A, Murata-Collins J, Weisenburger DD, Ngo VN.

Leuk Lymphoma. 2017 Mar;58(3):676-688. doi: 10.1080/10428194.2016.1198958. Epub 2016 Jun 24.

8.

Burkitt leukemia limited to the bone marrow has a better prognosis than Burkitt lymphoma with bone marrow involvement in adults.

Song JY, Venkataraman G, Fedoriw Y, Herrera AF, Siddiqi T, Alikhan MB, Kim YS, Murata-Collins J, Weisenburger DD, Liu X, Duffield AS.

Leuk Lymphoma. 2016;57(4):866-71. doi: 10.3109/10428194.2015.1085529. Epub 2015 Oct 8.

PMID:
26450341
9.

Late relapses following reduced intensity allogeneic transplantation in patients with multiple myeloma: a long-term follow-up study.

Sahebi F, Shen Y, Thomas SH, Rincon A, Murata-Collins J, Palmer J, Krishnan AY, Karanes C, Htut M, Somlo G, Forman SJ.

Br J Haematol. 2013 Jan;160(2):199-206. doi: 10.1111/bjh.12123. Epub 2012 Nov 15.

10.

Extramedullary relapse following reduced intensity allogeneic hematopoietic cell transplant for adult acute myelogenous leukemia.

Kogut N, Tsai NC, Thomas SH, Palmer J, Paris T, Murata-Collins J, Forman SJ.

Leuk Lymphoma. 2013 Mar;54(3):665-8. doi: 10.3109/10428194.2012.720375. Epub 2012 Sep 12. No abstract available.

11.

Sequential bortezomib, dexamethasone, and thalidomide maintenance therapy after single autologous peripheral stem cell transplantation in patients with multiple myeloma.

Sahebi F, Frankel PH, Farol L, Krishnan AY, Cai JL, Somlo G, Thomas SH, Reburiano E, Popplewell LL, Parker PM, Spielberger RT, Kogut NM, Karanes C, Htut M, Ruel C, Duarte L, Murata-Collins JL, Forman SJ.

Biol Blood Marrow Transplant. 2012 Mar;18(3):486-92. doi: 10.1016/j.bbmt.2011.12.580. Epub 2011 Dec 22.

12.

Embryonal rhabdomyosarcoma with a novel t(2;6)(p23;p21.1).

Pressey JG, Mroczek-Musulman E, Murata-Collins JL, Saito JM, Hammers Y.

Cancer Genet Cytogenet. 2008 Nov;187(1):39-42. doi: 10.1016/j.cancergencyto.2008.07.007.

PMID:
18992640
13.

Desmoplastic small round cell tumor of the kidney in childhood.

Wang LL, Perlman EJ, Vujanic GM, Zuppan C, Brundler MA, Cheung CR, Calicchio ML, Dubois S, Cendron M, Murata-Collins JL, Wenger GD, Strzelecki D, Barr FG, Collins T, Perez-Atayde AR, Kozakewich H.

Am J Surg Pathol. 2007 Apr;31(4):576-84.

PMID:
17414105
14.
15.

Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides.

Molina A, Zain J, Arber DA, Angelopolou M, O'Donnell M, Murata-Collins J, Forman SJ, Nademanee A.

J Clin Oncol. 2005 Sep 1;23(25):6163-71.

PMID:
16135483
16.

Ewing sarcoma as a second malignant neoplasm after acute lymphoblastic leukemia.

Kim GE, Beach B, Gastier-Foster JM, Murata-Collins JL, Rowland JM, O'Donnell RJ, Goldsby RE.

Pediatr Blood Cancer. 2005 Jul;45(1):57-9.

PMID:
15700259
17.

A patient with a ring chromosome 2 and microdeletion of 2q detected using FISH: Further support for "ring chromosome 2 syndrome".

Alkuraya FS, Kimonis VE, Holt L, Murata-Collins JL.

Am J Med Genet A. 2005 Feb 1;132A(4):447-9. Review. No abstract available.

PMID:
15580637
18.

Targeting multiple genetic aberrations in isolated tumor cells by spectral fluorescence in situ hybridization.

Slovak ML, Zhang F, Tcheurekdjian L, Bobadilla D, Bedell V, Arber DA, Persons DL, Sosman JA, Murata-Collins JL.

Cancer Detect Prev. 2002;26(3):171-9.

PMID:
12269763
19.

Minimal residual disease (MRD) in remission t(8;21) AML and in vivo differentiation detected by FISH and CD34+ cell sorting.

Varella-Garcia M, Hogan CJ, Odom LF, Murata-Collins JL, Ai H, Chen L, Richkind K, Paskulin G, Andreeff M, Brizard A, McGavran L, Gemmill RM, Berger R, Drabkin HA.

Leukemia. 2001 Sep;15(9):1408-14.

PMID:
11516101
20.

Simultaneous detection of multiple genetic aberrations in single cells by spectral fluorescence in situ hybridization.

Slovak ML, Tcheurekdjian L, Zhang FF, Murata-Collins JL.

Cancer Res. 2001 Feb 1;61(3):831-6.

21.

Twenty-four-color spectral karyotyping reveals chromosome aberrations in cytogenetically normal acute myeloid leukemia.

Zhang FF, Murata-Collins JL, Gaytan P, Forman SJ, Kopecky KJ, Willman CL, Appelbaum FR, Slovak ML.

Genes Chromosomes Cancer. 2000 Jul;28(3):318-28.

PMID:
10862038
22.

Ticlopidine-induced aplastic anemia: development of chromosomal abnormalities and response to immunosuppressive therapy.

Pullarkat VA, Rho H, Murata-Collins JL, Liebman HA.

Am J Hematol. 2000 Mar;63(3):141-4. Review.

PMID:
10679804
23.
24.

Surface immunoglobulin light chain-positive acute lymphoblastic leukemia of FAB L1 or L2 type: a report of 6 cases in adults.

Vasef MA, Brynes RK, Murata-Collins JL, Arber DA, Medeiros LJ.

Am J Clin Pathol. 1998 Aug;110(2):143-9.

PMID:
9704611
25.

Trisomy 14 in myelodysplastic syndromes: report of two cases and review of the literature.

Vasef MA, Murata-Collins JL, Alsabeh R, Medeiros LJ.

Arch Pathol Lab Med. 1998 Jan;122(1):77-83. Review.

PMID:
9448022
26.

Fetal cells in maternal blood: recovery by charge flow separation.

Wachtel SS, Sammons D, Manley M, Wachtel G, Twitty G, Utermohlen J, Phillips OP, Shulman LP, Taron DJ, Müller UR, Koeppen P, Ruffalo TM, Addis K, Porreco R, Murata-Collins J, Parker NB, McGavran L.

Hum Genet. 1996 Aug;98(2):162-6.

PMID:
8698333
27.

Natural size classes in DNA from Chinese hamster metaphase chromosomes.

Murata-Collins JL, Clark RW.

Chromosoma. 1987;95(1):44-50.

PMID:
3581998

Supplemental Content

Loading ...
Support Center